Guojin Securities released a research report saying that current investment in the medical device sector should closely follow the two-wheel drive logic of “going overseas to expand growth, innovate and protect profits,” while grasping the pace of domestic demand recovery. Under this framework, the core competitiveness of an enterprise no longer only depends on domestic market share, but also evaluates its overseas channel layout and ability to iterate original products. Going overseas can effectively diversify collection risks and open up growth ceilings, while continuous high-intensity R&D investment is a key moat for maintaining high gross profit margins and resisting price wars.

Guojin Securities released a research report saying that current investment in the medical device sector should closely follow the two-wheel drive logic of “going overseas to expand growth, innovate and protect profits,” while grasping the pace of domestic demand recovery. Under this framework, the core competitiveness of an enterprise no longer only depends on domestic market share, but also evaluates its overseas channel layout and ability to iterate original products. Going overseas can effectively diversify collection risks and open up growth ceilings, while continuous high-intensity R&D investment is a key moat for maintaining high gross profit margins and resisting price wars.